Home  >  News
  EMA accepts Fujifilm Kyowa Kirin Biologics' MAA for FKB327,   May 24, 2017
  Zydus receives US FDA marketing approval for cyproheptadine HCl tablets,   May 23, 2017
  Recordati to market AstraZeneca's hypertension, angina & heart failure drug, Seloken in Europe,   May 23, 2017
  Diplomat Pharmacy begins distribution of US FDA approved Rydapt to treat acute myeloid leukemia,   May 20, 2017
  Dr Reddy's Labs receives US FDA marketing approval for generic Doxil,   May 17, 2017
  Lannett receives US FDA approval for generic Xyzal oral solution,   May 17, 2017
  JW Pharma to market Chugai Pharma's emicizumab in Korea to treat haemophilia A,   May 11, 2017
  Hetro receives DCGI marketing approval for generic Epclusa,   May 05, 2017
  Study shows policy changes to restrict marketing activities at medical centers,   May 05, 2017
  Navamedic to market Orexigen Therapeutics' obesity drug, Mysimba in Denmark, Finland, Iceland, Norway & Sweden,   May 03, 2017
  Lupin receives US FDA marketing approval for generic Benicar tablets,   April 28, 2017
  AstraZeneca's Tagrisso gets EU marketing nod for patients with EGFR T790M mutation-positive NSCLC,   April 28, 2017
  Impax Labs introduces generic Vytorin in US market,   April 28, 2017
  Zydus Cadila receives US FDA approval to market cholesterol drug, cholestyramine,   April 27, 2017
  Dr. Reddy's Labs introduces generic Vytorin tablets in US market,   April 27, 2017
  Shire receives European conditional marketing approval for Natpar to treat patients with chronic hypoparathyroidism,   April 27, 2017
  Indian pharma to maximise quality, timelines & budgets to market drug products via digital platforms,   April 27, 2017
  Valeant Pharma seeks Canadian marketing approval for Contrave,   April 26, 2017
  Zydus gets US FDA marketing nod for olmesartan medoxomil tablets,   April 25, 2017
  Recipharm delivers first batch of serialised drug products to Saudi Arabia,   April 25, 2017

Copyright © 2016 Saffron Media Pvt. Ltd |